6-HYDROXY-8-((1R)-1-HYDROXY-2-(((2R)-2-HYDROXY-2-(6-HYDROXY-3-OXO-4H-1,4-BENZOXAZIN-8-YL)ETHYL)-(1-(4-METHOXYPHENYL)-2-METHYLPROPAN-2-YL)AMINO)ETHYL)-4H-1,4-BENZOXAZIN-3-ONE
UNII 3U79BQ5AB4
Substance Identification & Data
This profile provides standardized clinical and technical data for 6-hydroxy-8-((1r)-1-hydroxy-2-(((2r)-2-hydroxy-2-(6-hydroxy-3-oxo-4h-1,4-benzoxazin-8-yl)ethyl)-(1-(4-methoxyphenyl)-2-methylpropan-2-yl)amino)ethyl)-4h-1,4-benzoxazin-3-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3U79BQ5AB4.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C31H35N3O9 YFSQTMGEIIZYAW-UIOOFZCWSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6-hydroxy-8-((1r)-1-hydroxy-2-(((2r)-2-hydroxy-2-(6-hydroxy-3-oxo-4h-1,4-benzoxazin-8-yl)ethyl)-(1-(4-methoxyphenyl)-2-methylpropan-2-yl)amino)ethyl)-4h-1,4-benzoxazin-3-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.